SARA LEVY: Open Payments
NPI 1609380302 · HILLSBOROUGH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,466 in 147 payments from 22 companies in 2025. Trend: 2023 $205 · 2024 $2,000 · 2025 $2,466
Food & beverage: $2,224Education: $242
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $411 |
| ABBVIE INC. | 27 | $360 |
| Incyte Corporation | 22 | $277 |
| E.R. Squibb & Sons, L.L.C. | 18 | $237 |
| UCB, Inc. | 14 | $235 |
| MAYNE PHARMA COMMERCIAL LLC | 9 | $160 |
| Galderma Laboratories, L.P. | 11 | $145 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Amgen Inc. | 5 | $82 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $76 |
Products named: TREMFYA, OPZELURA, SKYRIZI, Sotyktu, Bimzelx, DUPIXENT, NEMLUVIO, RINVOQ.
Industry payments across NJ — which companies pay providers there.
